WJPR Citation New

  All Since 2019
 Citation  7475  4312
 h-index  28  21
 i10-index  197  83

Login

Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
Best Paper Award :
Dr. Dhrubo Jyoti Sen
Download Article: Click Here

Search

Track Your Article

Abstract

CLINICAL EVALUATION OF DASAMUL KWATH AND KATPHAL (MYRICA ESCULENTA) CHURNA FOR MANAGEMENT OF TAMAK SVASA (BRONCHIAL ASTHAMA)

Dr. Supriya Nandi Banerjee*, Prof. Dr. Mradu Gupta and Prof. Dr. Badri Prasad Shaw

.

Abstract

Background: Bronchial asthma is a global problem which creates a substantial burden on individuals and families restricting individual activities for a lifetime. WHO estimated that 262 million people suffer from asthma of which 455,000 people died globally in 2019. The clinical features of bronchial asthma are very much alike to disease Tamak svasa according to Ayurvedic system of medicine. There are several medicines which have been mentioned in the classical texts for the treatment of Tamak Svasa. The present clinical study was furnished to establish the effect of Dasamula kwath and Katphal churna (Myrica esculenta) in Tamaka Swasa vis-à-vis bronchial asthma. The goal of treatment is to control the symptoms of the disease effectively in a long run in a scientifically and methodical manner. Methods: Total 56 patients of Tamaka Swasa (Bronchial asthma) were selected and out of them clinical trial was performed with 30 patients. These 30 patients were selected after implying the inclusion & exclusion criteria and randomly categorized into three groups i.e. group A, B and C as per their treatment schedule. Patients of group ‘A’ (n = 06) were treated with 3 gm of Katphala churna along with 1gm of Pippali churna, group ‘B’ patients (n = 10) were treated with 20 ml of Dasamula kwath twice daily with 1gm of Pippali churna and group ‘C’ patients (n = 14) were simultaneously treated with 20 ml of Dasamula kwath with 3 gm of Katphala churna with 1gm of Pippali churna. All the treatments were continued twice per day for a period of 3 months (90 days). Signs, symptoms, pick expiratory flow rate, breath holding time and hematological parameter (routine blood examination) and chest skiagram were studied before and after treatment. Results: It was observed from the study that there were very close results in three groups of treatment where the per cent reduction of mean score of the symptoms in groups ‘A’, ‘B, and ‘C, were 48.31%, 44.45% and 53.92% respectively, PEFR reduction rate in these groups were 48.31%, 40% and 58.66% respectively while breath hold time (BHT) were 47.1%, 44% and 53.82% respectively. No significant changes of hematological parameters were observed in any groups. Conclusion: Combination of Ayurvedic management with Dasamula Kwath and Katpha Churna for the management bronchial asthma was found satisfactory.

Keywords: Tamak svsas, Bronchial asthma, Dasamula kwath, Katphal churna.


[Full Text Article]  [Download Certificate]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More